A detailed history of Cypress Capital Management LLC (Wy) transactions in Novo Nordisk A S stock. As of the latest transaction made, Cypress Capital Management LLC (Wy) holds 550 shares of NVO stock, worth $57,783. This represents 0.07% of its overall portfolio holdings.

Number of Shares
550
Previous 600 8.33%
Holding current value
$57,783
Previous $85,000 23.53%
% of portfolio
0.07%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$119.07 - $145.42 $5,953 - $7,270
-50 Reduced 8.33%
550 $65,000
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $61,266 - $81,551
600 New
600 $77,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cypress Capital Management LLC (Wy) Portfolio

Follow Cypress Capital Management LLC (Wy) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.